Stock analysts at StockNews.com initiated coverage on shares of Sorrento Therapeutics (NASDAQ:SRNE – Get Free Report) in a report released on Thursday. The firm set a “hold” rating on the ...

After being diagnosed with multiple myeloma, Valarie Traynham turned her journey into a mission—raising awareness, educating ...

IB-T101, a CD70-targeted chimeric antigen receptor therapy, is being studied for relapsed clear cell renal cell carcinoma ...

Researchers sought to determine whether CAR-T therapy with ide-cel would be effective in patients with triple-class–exposed relapsed/refractory MM.

More cost-effectiveness studies evaluating bispecific antibody or chimeric antigen receptor T-cell therapies are necessary for enhancing care in myeloma and lymphoma.

The collaboration will drive cord blood-derived allogeneic CAR T-cell development. Singapore General Hospital (SGH) has ...

Allogene Therapeutics published new long-term follow-up data on cemacabtagene ansegedleucel, showing the investigative ...

Anixa Biosciences (ANIX) announced has it has dosed its final patient in the third cohort of its ongoing Phase 1 clinical trial evaluating its ...

City of Hope® Research Spotlight offers a glimpse at groundbreaking scientific and clinical discoveries advancing lifesaving cures for patients with cancer, diabetes and other chronic, ...

Manipulating the immune system to treat cancer has generated phenomenal responses in some patients, including complete cures, ...

Laboratories International announced an agreement with Singapore General Hospital SGH to provide Current Good Manufacturing ...

From uncertainty to hope for the future, they offer advice on getting through some of the toughest years of their lives ...